To check the effect of Haridradi Anjan application in patients with complaints of Simple Allergic Conjunctivitis

Randomized control clinical trial to evaluate the efficacy of Haridradi Anjan in Vataja Abhishyanda w.s.r. to Simple Allergic Conjunctivitis - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081558

Enrollment

Registered

2025-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H101- Acute atopic conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age group - 18 to 50 years The patients presenting classical signs and symptoms of Vataja Abhishyanda

Exclusion criteria

Exclusion criteria: Patients having any other known ocular pathology. Any past or present history of ocular trauma. Patients with K/C/O Naso lacrimal duct block/ Dacryocystitis)

Design outcomes

Primary

Measure	Time frame
To Evaluate the Efficacy of Haridradi Anjan in Vataja Abhishyanda w.s.r. to Simple Allergic conjunctivitis.Timepoint: 21 days	—

Secondary

Measure	Time frame
Adverse reaction if anyTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Pragati Audumbar Sarvade

LKR Ayurvedic Mahavidyalaya Post Graduate Training and Research Center, Gadhinglaj, Kolhapur

drsutaryuvrajmsophth@gmail.com9850544418

Outcome results